1 Min Read
Oct 23 (Reuters) - TBG Diagnostics Ltd:
* Received approval from China FDA for portfolio of Human Leukocyte Antigen genotyping kits Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.